Home › Mga Sakit sa Dugo › California
Pag-aaral pangklinika para sa Mga Sakit sa Dugo sa California
19 pag-aaral para sa Mga Sakit sa Dugo ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
- Los Angeles10 pag-aaral
- Mountain View7 pag-aaral
- San Diego6 pag-aaral
- Baldwin Park4 pag-aaral
- Orange3 pag-aaral
- Sacramento3 pag-aaral
- San Francisco3 pag-aaral
Opisyal na teksto ng pag-aaral (English)
A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia
- University of California San Diego (UC San Diego) Health - Jacobs Medical Center, La Jolla
- Children's Hospital Los Angeles, Los Angeles
- University of California Davis (UC Davis) Medical Center, Sacramento
- at 1 pa
Nagre-recruitPhase 3
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07935356A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Ctr for Inherited Blood Disorders, Orange
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06439082Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
- University of California, San Diego, San Diego
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07601425A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06722235A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
- Dren Investigational Site, Duarte
- Dren Investigational Site, Palo Alto
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07712562Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- City of Hope Comprehensive Cancer Center, Duarte
- University of California, Irvine, Irvine
- USC Norris Comprehensive Cancer Center, Los Angeles
- at 2 pa
Nagre-recruitPhase 3
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07504458A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06948318A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- University of Southern California, Los Angeles
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07059000Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
- UC Davis Health, Sacramento
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT05423691A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Keck School of Medicine of USC, Los Angeles
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT04256317(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- City of Hope, Duarte
- Stanford University, Palo Alto
- UCSF, San Francisco
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07075185ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Orthopaedic Institute for Children HTC, Los Angeles
- Childrens Hospital Los Angeles, Los Angeles
- UCSF Benioff Children's Hospital Oakland, Oakland
- at 5 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Pacific Cancer Medical Center, Inc, Anaheim
- TOI Clinical Research, Cerritos
- Stanford School of Medicine-Cancer Clinical Trials Office, Palo Alto
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05254743Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- UCLA Department of Medicine, Los Angeles
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07216443Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
- USC / Norris Comprehensive Cancer Center, Los Angeles
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 pataas · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT03207854Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
- Lucile Packard Children's Hospital, Palo Alto
Nagre-recruitPhase 1
1 Month – 45 Years · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT04640987Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- Lucile Packard Children's Hospital, Palo Alto
Nagre-recruit
1 Month – 60 Years · Lahat ng kasarian · Na-update May 29, 2025 · NCT04249830The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
- LabPMM, San Diego
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update May 4, 2025 · NCT06222164Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.